<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72221">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01947842</url>
  </required_header>
  <id_info>
    <org_study_id>BUCOP-001</org_study_id>
    <nct_id>NCT01947842</nct_id>
  </id_info>
  <brief_title>Effect of a Smartphone Application on Oral Contraceptive Adherence in College Females</brief_title>
  <official_title>Effect of a Smartphone Application on Oral Contraceptive Adherence in College Females: a Randomized-controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Belmont University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Belmont University</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research study is to see if smartphone applications help college women remember to take
      birth control better than pharmacist consultation alone.  Patients will participate in this
      study for 6 (six) months.  The study will have two groups.  Patients will be randomly
      assigned to one group or the other.  The control group will be counseled by the pharmacist
      on the importance of taking birth control as prescribed.  The study group will get the same
      counseling, but will also be set up to receive reminders to take medication on a smartphone
      application called Dosecast.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2014</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Doses Missed</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of doses of oral contraceptive missed over a six-month period.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Adherence to Oral Contraceptive Therapy.</condition>
  <arm_group>
    <arm_group_label>Smartphone App</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The pharmacist will download and configure the Dosecast smartphone application to remind the patient to take their medication in addition to pharmacist counseling on the importance of adherence.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Counseling Alone</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This arm will receive only counseling from the pharmacist with no other intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Smartphone App Dosecast</intervention_name>
    <description>The Dosecast app is configured to remind the patient to take their medication.</description>
    <arm_group_label>Smartphone App</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female gender

          -  18-29 years of age

          -  current prescription for an OCP

          -  currently enrolled as a student at the institution associated with the   pharmacy

          -  possession of a compatible smartphone.

        Exclusion Criteria:

          -  Pregnant patients

          -  Patients who become pregnant during the study will discontinue, but their data up
             until time of discontinuation will be used

          -  Patients using other forms of contraception (patch, injection, IUD, intra-vaginal
             ring, implant).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>29 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Adam Pace</last_name>
    <phone>6154606040</phone>
    <email>adam.pace@belmont.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Auburn University</name>
      <address>
        <city>Auburn</city>
        <state>Alabama</state>
        <zip>36849</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kimberly Braxton Lloyd, PharmD</last_name>
      <phone>334-844-4099</phone>
      <email>lloydkb@auburn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Mississippi</name>
      <address>
        <city>Oxford</city>
        <state>Mississippi</state>
        <zip>38677</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sandra Bentley, PharmD</last_name>
      <phone>662-915-5279</phone>
      <email>sbentley@olemiss.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Belmont University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Adam Pace, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 20, 2013</lastchanged_date>
  <firstreceived_date>September 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Belmont University</investigator_affiliation>
    <investigator_full_name>Adam Pace</investigator_full_name>
    <investigator_title>Assistant Professor of Pharmacy Practice</investigator_title>
  </responsible_party>
  <keyword>Smartphone</keyword>
  <keyword>adherence</keyword>
  <keyword>contraceptives</keyword>
  <keyword>college</keyword>
  <keyword>females</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Contraceptive Agents</mesh_term>
    <mesh_term>Contraceptives, Oral</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
